Prognostic and predictive impact of gene expression in node‐positive early breast cancer patients receiving dose‐dense versus standard‐dose adjuvant chemotherapy

The utility of multigene expression assays in advanced (≥ 4 positive lymph nodes) early breast cancer (EBC) is limited. We conducted exploratory transcriptomic analysis of 758 genes (Breast Cancer 360 panel, nCounter® platform; NanoString) in primary tumor samples collected during a phase 3 trial co...

Volledige beschrijving

Bibliografische gegevens

Hoofdauteurs:	Mattea Reinisch, Simona Bruzas, Oleg Gluz, Beyhan Ataseven, Peter Schmid, Javier Cortés, Jens‐Uwe Blohmer, Satyendra Shenoy, Mark H. Dyson, Christine Dittmer‐Grabowski, Ouafaa Chiari, Hakima Harrach, Daniel Gebauer, Alexander Traut, Sherko Kuemmel
Formaat:	Artigo
Taal:	Inglês
Gepubliceerd in:	Wiley 2023-06-01
Reeks:	Molecular Oncology
Onderwerpen:	adjuvant chemotherapy dose‐dense chemotherapy early breast cancer gene signature lymph node‐positive
Online toegang:	https://doi.org/10.1002/1878-0261.13435
Tags:	Voeg label toe Geen labels, Wees de eerste die dit record labelt!